ShareHope Medicine Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Ching-Wen Liu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.05% |
| Management average tenure | no data |
| Board average tenure | 1.6yrs |
Recent management updates
Recent updates
ShareHope Medicine's (GTSM:8403) Returns On Capital Are Heading Higher
Mar 26
Is ShareHope Medicine (GTSM:8403) Using Too Much Debt?
Feb 12
ShareHope Medicine Co., Ltd. (GTSM:8403) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Jan 15What We Make Of ShareHope Medicine's (GTSM:8403) Returns On Capital
Dec 16Investors Who Bought ShareHope Medicine (GTSM:8403) Shares A Year Ago Are Now Up 26%
Nov 18CEO
Ching-Wen Liu
no data
Tenure
Mr. Ching-Wen Liu serves as General Manager and Director at ShareHope Medicine Co., Ltd. He has M.B.A. from College Of Management,Yuan Ze University. He attended College of Medicine, National Taiwan Univer...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | no data | 0.045% NT$ 1.7m | |
| Independent Director | no data | no data | no data | |
| Director | no data | no data | no data | |
| Board Member | no data | no data | 1.12% NT$ 42.0m | |
| Board Member | no data | no data | no data | |
| Director | 1.6yrs | no data | no data | |
| Independent Director | 1.6yrs | no data | no data | |
| Independent Director | no data | no data | no data | |
| Chairman of Board | less than a year | no data | no data |
1.6yrs
Average Tenure
Experienced Board: 8403's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 19:39 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ShareHope Medicine Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pinghan Hsieh | Capital Securities Corporation |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Xinkai Yu | Masterlink Securities Corp. |